{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:00:06Z","timestamp":1772611206294,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19QA1407200"],"award-info":[{"award-number":["19QA1407200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejphar.2023.175529","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T08:47:47Z","timestamp":1674204467000},"page":"175529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2\/STAT3 signaling pathway"],"prefix":"10.1016","volume":"942","author":[{"given":"Xinglong","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingqi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengdong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-9913","authenticated-orcid":false,"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175529_bib1","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/MCB.21.5.1621-1632.2001","article-title":"Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver","volume":"21","author":"Alonzi","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175529_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109477","article-title":"beta-elemonic acid inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells through the suppression of JAK2\/STAT3\/MCL-1 and NF-kB signal pathways","volume":"342","author":"Bao","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2023.175529_bib3","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.4081\/rt.2017.6955","article-title":"Osteosarcoma of the Larynx: treatment outcomes and patterns of failure analysis","volume":"9","author":"Bennion","year":"2017","journal-title":"Rare Tumors"},{"key":"10.1016\/j.ejphar.2023.175529_bib4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2174\/1871520620666191220142741","article-title":"The anticancer properties of silibinin: its molecular mechanism and therapeutic effect in breast cancer","volume":"20","author":"Binienda","year":"2020","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejphar.2023.175529_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1182\/blood-2017-04-742288","article-title":"JAK2 inhibitors for myeloproliferative neoplasms: what is next?","volume":"130","author":"Bose","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175529_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yexmp.2005.11.003","article-title":"Systemic evaluation of total Stat3 and Stat3 tyrosine phosphorylation in normal human tissues","volume":"80","author":"Chen","year":"2006","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejphar.2023.175529_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fonc.2017.00203","article-title":"Three-dimensional patient-derived in vitro sarcoma models: promising tools for improving clinical tumor management","volume":"7","author":"Gaebler","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2023.175529_bib8","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1172\/JCI31871","article-title":"Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas","volume":"117","author":"Gao","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.175529_bib9","first-page":"7837","article-title":"Telocinobufagin inhibits the epithelial-mesenchymal transition of breast cancer cells through the phosphoinositide 3-kinase\/protein kinase B\/extracellular signal-regulated kinase\/Snail signaling pathway","volume":"15","author":"Gao","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejphar.2023.175529_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.oraloncology.2015.11.022","article-title":"The STAT3 pathway as a therapeutic target in head and neck cancer: barriers and innovations","volume":"56","author":"Geiger","year":"2016","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejphar.2023.175529_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2023.175529_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092566","article-title":"Telocinobufagin, a novel cardiotonic steroid, promotes renal fibrosis via Na(+)\/K(+)-ATPase profibrotic signaling pathways","volume":"19","author":"Kennedy","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175529_bib13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/ptr.6918","article-title":"8-Epi-xanthatin induces the apoptosis of DU145 prostate carcinoma cells through signal transducer and activator of transcription 3 inhibition and reactive oxygen species generation","volume":"35","author":"Lee","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2023.175529_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1172\/JCI0215650","article-title":"What does Stat3 do?","volume":"109","author":"Levy","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.175529_bib15","article-title":"Recent advances in liver cancer stem cells: non-coding RNAs, oncogenes and oncoproteins","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2023.175529_bib16","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/iub.2520","article-title":"Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2\/STAT3 signaling pathway via miR-375","volume":"73","author":"Li","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejphar.2023.175529_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115481","article-title":"Anthraquinone derivative C10 inhibits proliferation and cell cycle progression in colon cancer cells via the Jak2\/Stat3 signaling pathway","volume":"418","author":"Li","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175529_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.21037\/atm-22-73","article-title":"Polydatin down-regulates the phosphorylation level of STAT3 and induces pyroptosis in triple-negative breast cancer mice with a high-fat diet","volume":"10","author":"Liu","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejphar.2023.175529_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105525","article-title":"Bioactivity of natural biflavonoids in metabolism-related disease and cancer therapies","volume":"167","author":"Menezes","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2023.175529_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons","volume":"125","author":"Mirabello","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2023.175529_bib21","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results Program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2023.175529_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2014.02.003","article-title":"Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells?","volume":"62","author":"Mutsaers","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.ejphar.2023.175529_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246228","article-title":"Multicellular effects of STAT3 in non-small cell lung cancer: mechanistic insights and therapeutic opportunities","volume":"13","author":"Parakh","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2023.175529_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080854","article-title":"Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation","volume":"8","author":"Perner","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2023.175529_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.780264","article-title":"Osteosarcoma and metastasis","volume":"11","author":"Sheng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2023.175529_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bcp.2005.12.017","article-title":"JAK\/STAT signal transduction: regulators and implication in hematological malignancies","volume":"71","author":"Valentino","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175529_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bjh.12274","article-title":"The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis","volume":"161","author":"Verstovsek","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2023.175529_bib28","doi-asserted-by":"crossref","first-page":"34029","DOI":"10.1074\/jbc.M803012200","article-title":"JAK2\/STAT2\/STAT3 are required for myogenic differentiation","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175529_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbrc.2017.10.054","article-title":"Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis","volume":"495","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2023.175529_bib30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1631\/jzus.B2000842","article-title":"Blocking the JAK2\/STAT3 and ERK pathways suppresses the proliferation of gastrointestinal cancers by inducing apoptosis","volume":"22","author":"Wang","year":"2021","journal-title":"J. Zhejiang Univ. - Sci. B"},{"key":"10.1016\/j.ejphar.2023.175529_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41419-022-04806-9","article-title":"Osteopontin promotes hepatocellular carcinoma progression through inducing JAK2\/STAT3\/NOX1-mediated ROS production","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.175529_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jb\/mvab129","article-title":"CircRPPH1 promotes cell proliferation, migration and invasion of non-small cell lung cancer via the PI3K\/AKT and JAK2\/STAT3 signalling axes","volume":"171","author":"Xiong","year":"2022","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejphar.2023.175529_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5114\/fn.2019.83827","article-title":"Ginkgetin aglycone attenuates neuroinflammation and neuronal injury in the rats with ischemic stroke by modulating STAT3\/JAK2\/SIRT1","volume":"57","author":"Xu","year":"2019","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.ejphar.2023.175529_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2012.12.030","article-title":"Gastrin acting on the cholecystokinin2 receptor induces cyclooxygenase-2 expression through JAK2\/STAT3\/PI3K\/Akt pathway in human gastric cancer cells","volume":"332","author":"Xu","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2023.175529_bib35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2023.175529_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114915","article-title":"Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2\/STAT3 signalling pathway in colorectal cancer","volume":"287","author":"Zhang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2023.175529_bib37","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1158\/0008-5472.CAN-12-3175","article-title":"A novel inhibitor of STAT3 homodimerization selectively suppresses STAT3 activity and malignant transformation","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2023.175529_bib38","article-title":"Chenodeoxycholic acid enhances the effect of sorafenib in inhibiting HepG2 cell growth through EGFR\/Stat3 pathway","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2023.175529_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153172","article-title":"Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2\/STAT3 (T705) and mTOR\/STAT3 (S727) signaling pathways in colorectal cancer","volume":"68","author":"Zhang","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2023.175529_bib40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41401-020-0499-y","article-title":"10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation","volume":"42","author":"Zhao","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.175529_bib41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13046-018-0914-0","article-title":"Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells","volume":"37","author":"Zuo","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923000407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923000407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:41:53Z","timestamp":1736347313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923000407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":41,"alternative-id":["S0014299923000407"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175529","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the JAK2\/STAT3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175529"}}